Instructors
Willemijn van der Spuij, MSc
Executive Director, WorldWide Patient Safety International, Europe, Switzerland
Responsible for Pharmacovigilance activities in the EU and Balkans, as well as PV Intelligence and Operational activities within the International PV organization. As part of the Operational activities she holds responsibility for the PSMF. She previously served as Intelligence and Training expert in PV as part of the Quality Standards and Training Group in Bristol Myers Squibb and managed PV projects. Willemijn is a member of the EFPIA Pharmacovigilance Expert Working Group and the International Pharmacovigilance Group where she chairs the CIS and Balkan sub-teams. She started her career in Quintiles, followed by Aventis where she was involved in GCP activities.
Clare Lavery, MSc
Pharmacovigilance Excellence Principal, AstraZeneca, United Kingdom
To date, the majority of Clare’s career has been in Regulatory Affairs working for companies such as Boehringer Ingelheim and Johnson & Johnson. Clare’s broad regulatory experience has been gained at the local affiliate level, in EU and US Regulatory Affairs supporting drug development and maintenance projects and in EU Regulatory Policy. Three years ago Clare moved to a Patient Safety role at AstraZeneca, joining the QPPV Office and one of her responsibilities is coordinating PSMF maintenance.
Dionne Usher
Associate Director, Office of the EU QPPV, Merck Sharp & Dohme Limited, United Kingdom
Dionne works in the Office of the EU QPPV for MSD in the UK as the PSMF Owner. Interested in “all things PSMF” and other primary areas of support are EudraVigilance access management, PV Audits and Inspections and ad hoc EU QPPV Office projects and activities.